Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer

BACKGROUND: Histological grade (HG) has been used in the MonrachE trial to select patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive high-risk early breast cancer (EBC). Although nuclear grade (NG) is widely used in Japan, it is stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Takeshi, Yoshida, Masayuki, Shiino, Sho, Watase, Chikashi, Ogawa, Ayumi, Shikata, Shohei, Hashiguchi, Hiromi, Yoshii, Yukiko, Sugino, Hirokazu, Jimbo, Kenjiro, Maeshima, Akiko, Iwamoto, Eriko, Takayama, Shin, Suto, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587205/
https://www.ncbi.nlm.nih.gov/pubmed/37612443
http://dx.doi.org/10.1007/s12282-023-01500-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587205/
https://www.ncbi.nlm.nih.gov/pubmed/37612443
http://dx.doi.org/10.1007/s12282-023-01500-2

Ejemplares similares